Hologic Inc (HOLX) - Financial and Strategic SWOT Analysis Review
Description
Hologic Inc (HOLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Hologic Inc (Hologic) is a medical technology company that develops, manufactures, and distributes medical diagnostics, imaging systems and surgical devices. Hologic's products include molecular diagnostic instrumentation, digital diagnostics systems, rapid fetal fibronectin test, oncology products, stereotactic breast biopsy systems, breast biopsy and surgery products, endometrial ablation system, fluid management system, bone densitometry, and mini-C-arm imaging system, among others. Its products are offered to clinical laboratories, hospitals, healthcare providers, and surgeons in both hospital and office settings, gynecologists, radiologists, and breast surgeons. The company distributes its products through direct sales, service personnel, and a network of independent distributors and sales representatives in North America, Europe, Asia Pacific, the Middle East, and Africa. Hologic is headquartered in Marlborough, Massachusetts, the US.
Hologic Inc Key Recent Developments
Nov 12,2025: Hologic Expands Digital Pathology Capabilities with CE Marking
Oct 30,2025: Hologic Achieves 75% Reduction in Order Processing Costs With Commport's Integrated EDI Solution
Oct 21,2025: Hologic Reports Fourth Quarter Financial Results for Fiscal 2025
Oct 02,2025: Hologic Receives FDA Clearance And CE Mark For Automated Molecular Tests To Detect Infectious Gastroenteritis
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Hologic Inc (Hologic) is a medical technology company that develops, manufactures, and distributes medical diagnostics, imaging systems and surgical devices. Hologic's products include molecular diagnostic instrumentation, digital diagnostics systems, rapid fetal fibronectin test, oncology products, stereotactic breast biopsy systems, breast biopsy and surgery products, endometrial ablation system, fluid management system, bone densitometry, and mini-C-arm imaging system, among others. Its products are offered to clinical laboratories, hospitals, healthcare providers, and surgeons in both hospital and office settings, gynecologists, radiologists, and breast surgeons. The company distributes its products through direct sales, service personnel, and a network of independent distributors and sales representatives in North America, Europe, Asia Pacific, the Middle East, and Africa. Hologic is headquartered in Marlborough, Massachusetts, the US.
Hologic Inc Key Recent Developments
Nov 12,2025: Hologic Expands Digital Pathology Capabilities with CE Marking
Oct 30,2025: Hologic Achieves 75% Reduction in Order Processing Costs With Commport's Integrated EDI Solution
Oct 21,2025: Hologic Reports Fourth Quarter Financial Results for Fiscal 2025
Oct 02,2025: Hologic Receives FDA Clearance And CE Mark For Automated Molecular Tests To Detect Infectious Gastroenteritis
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
68 Pages
- Section 1 - About the Company
- Hologic Inc - Key Facts
- Hologic Inc - Key Employees
- Hologic Inc - Key Employee Biographies
- Hologic Inc - Major Products and Services
- Hologic Inc - History
- Hologic Inc - Company Statement
- Hologic Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Affiliate
- Section 2 – Company Analysis
- Company Overview
- Hologic Inc - Business Description
- Business Segment: Breast Health
- Overview
- Performance
- Business Segment: Diagnostics
- Overview
- Performance
- Business Segment: GYN Surgical
- Overview
- Performance
- Business Segment: Skeletal Health
- Overview
- Performance
- Geographical Segment: Asia-Pacific
- Performance
- Geographical Segment: Europe
- Performance
- Geographical Segment: Rest of World
- Performance
- Geographical Segment: United States
- Performance
- R&D Overview
- Hologic Inc - Corporate Strategy
- Hologic Inc - SWOT Analysis
- SWOT Analysis - Overview
- Hologic Inc - Strengths
- Hologic Inc - Weaknesses
- Hologic Inc - Opportunities
- Hologic Inc - Threats
- Hologic Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Hologic Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Hologic Inc, Medical Equipment, Deals By Type, 2020 to YTD 2026
- Hologic Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Nov 12, 2025: Hologic Expands Digital Pathology Capabilities with CE Marking
- Oct 30, 2025: Hologic Achieves 75% Reduction in Order Processing Costs With Commport's Integrated EDI Solution
- Oct 21, 2025: Hologic Reports Fourth Quarter Financial Results for Fiscal 2025
- Oct 02, 2025: Hologic Receives FDA Clearance And CE Mark For Automated Molecular Tests To Detect Infectious Gastroenteritis
- Sep 29, 2025: Minicarm.com Secures U.S. Distribution Rights for Hologic's Fluoroscan Insight FD Mini C-Arm
- Sep 26, 2025: New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI
- Jul 02, 2025: Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025
- Jun 02, 2025: NEST Adds Hologic to Governance Committee
- Apr 08, 2025: Wayde McMillan Elected to Hologic Board of Directors
- Mar 03, 2025: Hologic : Departure of Directors or Certain Officers ; Election of Directors
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Hologic Inc, Key Facts
- Hologic Inc, Key Employees
- Hologic Inc, Key Employee Biographies
- Hologic Inc, Major Products and Services
- Hologic Inc, History
- Hologic Inc, Other Locations
- Hologic Inc, Subsidiaries
- Hologic Inc, Affiliate
- Hologic Inc, Key Competitors
- Hologic Inc, Ratios based on current share price
- Hologic Inc, Annual Ratios
- Hologic Inc, Annual Ratios (Cont...1)
- Hologic Inc, Annual Ratios (Cont...2)
- Hologic Inc, Interim Ratios
- Hologic Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Hologic Inc, Medical Equipment, Deals By Type, 2020 to YTD 2026
- Hologic Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Hologic Inc, Performance Chart (2021 - 2025)
- Hologic Inc, Ratio Charts
- Hologic Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Hologic Inc, Medical Equipment, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

